Tumour-Associated Macrophages in Oral Squamous Cell Carcinoma

被引:2
作者
Chaurasia, Akhilanand [1 ]
Brigi, Carel [2 ]
Daghrery, Arwa [3 ]
Asa'ad, Farah [4 ]
Spirito, Francesca [5 ]
Hasuike, Akira [6 ]
Gonzalez-Alva, Patricia [7 ]
Kojic, Dave D. [8 ]
Unsal, Revan Birke Koca [9 ]
Sivaramakrishnan, Gowri [10 ]
机构
[1] King Georges Med Univ, Dept Oral Med & Radiol, Lucknow, India
[2] Univ Sharjah, Res Inst Med & Hlth Sci 2, Sharjah, U Arab Emirates
[3] Jazan Univ, Coll Dent, Dept Restorat Dent Sci, Jazan, Saudi Arabia
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Dept Oral Biochem, Gothenburg, Sweden
[5] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy
[6] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo, Japan
[7] Univ Nacl Autonoma Mexico, Fac Odontol, DEPeI, Mexico City, Mexico
[8] AT Still Univ, Missouri Sch Dent & Oral Hlth, Kirksville, MO 63501 USA
[9] Western Univ, Schulich Sch Med & Dent, Dept Periodont, London, ON, Canada
[10] Bahrain Def Force Royal Med Serv, Riffa, Bahrain
关键词
head and neck neoplasm; neoplasm invasiveness; neoplasm metastasis; oral cancer; phagocytes; tumour microenvironment; CD163-POSITIVE MACROPHAGES; TUMORICIDAL PROPERTIES; PANCREATIC-CANCER; POOR-PROGNOSIS; METASTASIS; EXPRESSION; HEAD; MONOCYTES; PROTEIN; MICROENVIRONMENT;
D O I
10.1111/odi.15265
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectiveTumour-associated macrophages (TAMs) are crucial in the progression and treatment response of oral squamous cell carcinoma (OSCC). TAMs infiltrate OSCC, adopting an M2-like phenotype that promotes tumour growth, metastasis and immune suppression. The current narrative review explored the roles of TAMs in OSCC, focusing on their impact on the tumour microenvironment, invasion, metastasis, angiogenesis, immunosuppression and potential therapeutic targeting.MethodsA comprehensive analysis of the current literature on TAMs in OSCC was conducted. Specifically, we evaluated the biological functions of TAMs, their interactions within the tumour microenvironment, and their influence on disease progression and treatment outcomes.ResultsTAMs contribute to OSCC progression by secreting cytokines, such as IL-10 and TGF-beta, that inhibit effector immune cells. They facilitate angiogenesis, extracellular matrix remodelling and the epithelial-mesenchymal transition, which are essential for tumour invasion and metastasis. TAMs support cancer stem cells and recruit regulatory T cells and myeloid-derived suppressor cells, enhancing resistance to therapies. Their presence correlates with advanced OSCC stages, lymph node metastasis and poor prognosis.ConclusionTAMs regulate OSCC progression and therapy resistance. Reprogramming them to an M1-like phenotype or depleting them enhances treatments. Understanding TAM-OSCC interactions is crucial for developing interventions against their tumour-promoting functions and restoring anti-tumour immunity.
引用
收藏
页码:1546 / 1563
页数:18
相关论文
共 104 条
[1]   The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage [J].
Abu Lila, Amr S. ;
Kiwada, Hiroshi ;
Ishida, Tatsuhiro .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :38-47
[2]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[3]   Macrophages and prognosis of oral squamous cell carcinoma: A systematic review [J].
Alves, Alessandro Menna ;
Diel, Leonardo Francisco ;
Lamers, Marcelo Lazzaron .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (05) :460-467
[4]   SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors [J].
Alvey, Cory M. ;
Spinler, Kyle R. ;
Irianto, Jerome ;
Pfeifer, Charlotte R. ;
Hayes, Brandon ;
Xia, Yuntao ;
Cho, Sangkyun ;
Dingal, P. C. P. Dave ;
Hsu, Jake ;
Smith, Lucas ;
Tewari, Manu ;
Discher, Dennis E. .
CURRENT BIOLOGY, 2017, 27 (14) :2065-+
[5]   Targeting tumor associated macrophages: The new challenge for nanomedicine [J].
Andon, Fernando Torres ;
Digifico, Elisabeth ;
Maeda, Akihiro ;
Erreni, Marco ;
Mantovani, Alberto ;
Jose Alonso, Maria ;
Allavena, Paola .
SEMINARS IN IMMUNOLOGY, 2017, 34 (0C) :103-113
[6]  
Azoury SC, 2016, DISCOV MED, V21, P507
[7]   Neuropilins in Tumor Biology [J].
Bagri, Anil ;
Tessier-Lavigne, Marc ;
Watts, Ryan J. .
CLINICAL CANCER RESEARCH, 2009, 15 (06) :1860-1864
[8]   Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial) [J].
Barnes, David J. ;
Dutton, Peter ;
Bruland, Oyvind ;
Gelderblom, Hans ;
Faleti, Ade ;
Buhnemann, Claudia ;
van Maldegem, Annemiek ;
Johnson, Hannah ;
Poulton, Lisa ;
Love, Sharon ;
Tiemeier, Gesa ;
van Beelen, Els ;
Herbschleb, Karin ;
Haddon, Caroline ;
Billingham, Lucinda ;
Bradley, Kevin ;
Ferrari, Stefano ;
Palmerini, Emanuela ;
Picci, Piero ;
Dirksen, Uta ;
Strauss, Sandra J. ;
Hogendoorn, Pancras C. W. ;
Buddingh, Emmeline ;
Blay, Jean-Yves ;
Cleton-Jansen, Anne Marie ;
Hassan, Andrew Bassim .
BMC CANCER, 2022, 22 (01)
[9]   Targeting TREM2 on tumor-associated macrophages enhances immunotherapy [J].
Binnewies, Mikhail ;
Pollack, Joshua L. ;
Rudolph, Joshua ;
Dash, Subhadra ;
Abushawish, Marwan ;
Lee, Tian ;
Jahchan, Nadine S. ;
Canaday, Pamela ;
Lu, Erick ;
Norng, Manith ;
Mankikar, Shilpa ;
Liu, Victoria M. ;
Du, Xiaoyan ;
Chen, Amanda ;
Mehta, Ranna ;
Palmer, Rachael ;
Juric, Vladislava ;
Liang, Linda ;
Baker, Kevin P. ;
Reyno, Leonard ;
Krummel, Matthew F. ;
Streuli, Michel ;
Sriram, Venkataraman .
CELL REPORTS, 2021, 37 (03)
[10]   Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery [J].
Bouzin, Caroline ;
Feron, Olivier .
DRUG RESISTANCE UPDATES, 2007, 10 (03) :109-120